Morgan Lewis (Philadelphia)

Zachary M. Johns

Morgan Lewis (Philadelphia)
Partner

Zachary Johns is a partner with Morgan Lewis in their Philadelphia office. He represents US and international clients in a variety of high-stakes complex commercial matters with a focus on civil and criminal antitrust and class action litigation. He also counsels businesses on antitrust and litigation risks and advises on risk management strategies. He represents companies across a broad range of industries, including financial services, pharmaceutical, food manufacturing, consumer products, aviation, and building products.

Auteurs associés

Morgan Lewis (Washington)
Morgan Lewis (London)
Morgan Lewis (London)
Morgan Lewis (New York)
Morgan Lewis (Chicago)

Articles

1045 Bulletin

Zachary M. Johns, Ryan Kantor, Jonathan M. Rich, Stephen LaBrecque The US District Court for the Eastern District of Louisiana holds that the hospital merger is exempt from Hart-Scott-Rodino Filing under the state action doctrine (Louisiana Children’s Medical Center / HCA Healthcare)

51

A US district court judge, in a case of first impression, recently held that Louisiana Children’s Medical Center’s acquisition of three New Orleans–area hospitals from HCA Healthcare, Inc. was exempt from both the federal antitrust laws and the Hart-Scott-Rodino (HSR) Act premerger (...)

Zachary M. Johns, Ryan Kantor The US FTC sues a provider of anaesthesia services for allegedly enacting an anticompetitive scheme to gain market power through a series of roll-up acquisitions (USAP / Welsh Carson)

69

The US Federal Trade Commission is suing US Anesthesia Partners Inc. and its private equity founder for allegedly enacting an anticompetitive scheme to gain market power through a series of roll-up acquisitions. FTC V. US ANESTHESIA PARTNERS INC. On September 21, 2023, the US Federal (...)

Zachary M. Johns, Jonathan D. Morris, Banee Pachuca, Christopher Miller The US State of New York Assembly amends the Public Health Law to impose new notification requirements related to material transactions involving physician practices and management services organizations

133

NEW YORK STATE : HEALTHCARE ENTITIES MUST DISCLOSE CERTAIN MATERIAL TRANSACTIONS* As part of the New York State budget for fiscal year 2023–2024, the New York State Assembly amended the New York Public Health Law to impose new notification requirements related to material transactions (...)

William McEnroe, Brendan Fee, Zachary M. Johns, Ryan Kantor, Steven A. Reed, Daniel S. Savrin, Mark J. Fanelli The US DoJ rescinds three longstanding pieces of guidance on the exchange of competitively sensitive information through third parties

78

The US Department of Justice (DOJ) Antitrust Division is withdrawing three enforcement policy statements that provided important guidance on the exchange of competitively sensitive information through third parties. The guidance previously created a safe harbor for market benchmarking surveys (...)

J. Clayton Everett, Jr., Zachary M. Johns, Michael p. Jones, Debra L. Fischer, Seth Gerber, Johnathon Bramble, Patrick Huyett The US FTC proposes a rule that would ban employers from entering into and maintaining noncompete clauses with their workers

70

The Federal Trade Commission (FTC) announced a notice of proposed rule making (NPRM) on January 5, 2023, that would ban employers from entering into and maintaining noncompete clauses with their workers. With this potential ability for workers to change jobs more freely, employers will become (...)

Zachary M. Johns, Daniel S. Savrin, Mark J. Fanelli, Brian Morris The US District Court for the District of Delaware enters a federal jury’s verdict sanctioning a company for committing antitrust violations under Sections 1 and 2 of the Sherman Act in the honeycomb carbon adsorbents scrubbers in fuel vapor canisters market (BASF / Ingevity)

310

A recent BASF jury verdict highlights the breadth of the Sherman and Clayton Acts—particularly the remedies available to plaintiffs involved in the manufacturing of goods—if supply agreements are found to hinder marketplace competition. The verdict serves as an important reminder for (...)

Bernard W. Archbold, Zachary M. Johns, Ryan Kantor, David R. Brenneman The US FTC loses bid to stop Philadelphia hospital merger (Thomas Jefferson University / Albert Einstein Healthcare Network)

103

On December 8, 2020, Judge Gerald Pappert in the US District Court for the Eastern District of Pennsylvania denied a request from the Federal Trade Commission (FTC) and Pennsylvania attorney general (AG) to preliminarily enjoin a proposed merger between Thomas Jefferson University (TJU) and (...)

Statistiques


1045
Total des visites

130.6
Nombre de lectures par contribution

8
Nombre de contributions

Classement de l'auteur
1263ème
En nombre de contributions
4393ème
En nombre total de visites
7566ème
En nombre moyen de visites
Envoyer un message